BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24139183)

  • 21. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography.
    Ungermann L; Eliás P; Zizka J; Ryska P; Klzo L
    Eur J Radiol; 2007 Aug; 63(2):290-4. PubMed ID: 17353110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography.
    Huang-Wei C; Bleuzen A; Bourlier P; Roumy J; Bouakaz A; Pourcelot L; Tranquart F
    Invest Radiol; 2006 Mar; 41(3):363-8. PubMed ID: 16481921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases.
    Attal P; Vilgrain V; Brancatelli G; Paradis V; Terris B; Belghiti J; Taouli B; Menu Y
    Radiology; 2003 Aug; 228(2):465-72. PubMed ID: 12819340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
    van den Esschert JW; van Gulik TM; Phoa SS
    Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison Between SonoVue and Sonazoid Contrast-Enhanced Ultrasound in Characterization of Focal Nodular Hyperplasia Smaller Than 3 cm.
    He M; Zhu L; Huang M; Zhong L; Ye Z; Jiang T
    J Ultrasound Med; 2021 Oct; 40(10):2095-2104. PubMed ID: 33305869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
    Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography.
    Kim TK; Jang HJ; Burns PN; Murphy-Lavallee J; Wilson SR
    AJR Am J Roentgenol; 2008 Jan; 190(1):58-66. PubMed ID: 18094294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic scoring of liver biopsy in focal nodular hyperplasia with atypical presentation.
    Fabre A; Audet P; Vilgrain V; Nguyen BN; Valla D; Belghiti J; Degott C
    Hepatology; 2002 Feb; 35(2):414-20. PubMed ID: 11826417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contrast-enhanced ultrasound in hepatic focal nodular hyperplasia].
    Gorur Y; Coibion C; Magotteaux P
    Rev Med Liege; 2012 Mar; 67(3):113-7. PubMed ID: 22611826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size.
    Bertin C; Egels S; Wagner M; Huynh-Charlier I; Vilgrain V; Lucidarme O
    Eur Radiol; 2014 Oct; 24(10):2561-71. PubMed ID: 24962831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal nodular hyperplasia: our experience of 53 Japanese cases.
    Naganuma H; Ishida H; Ogawa M; Watanabe Y; Watanabe D; Ohyama Y; Watanabe T
    J Med Ultrason (2001); 2017 Jan; 44(1):79-88. PubMed ID: 27550510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.
    Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A
    Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.